According to the Journal Citation Report from 2011, the journals impact factor is rated at 6.873. According to the Journal Citation Report from 2011, the journal's impact factor is rated at 4.218. Current Molecular Medicine is an interdisciplinary journal focused on providing the readership with current and comprehensive reviews on fundamental molecular mechanisms of disease pathogenesis, the development of molecular-diagnosis and/or novel approaches to rational treatment. Human Gene Therapy Methods Impact Factor, IF, number of article, detailed information … Impact Factor: * 3.611 *2019 Journal Citation Reports (Clarivate, 2020) The leading journal for publishing data relevant to the regulatory review and commercial development of cell and gene therapy products. Human gene therapy. The Journal Impact 2019-2020 of Human gene therapy. The Journal publishes scientific papers on original investigations into the transfer and expression of genes in mammals, including humans. The diagnostic role of genetic processes is clear, but major benefits in health and disease are also provided by other molecules: enzymes, antibiotics, hormones, metals, carbohydrates, lipids, vitamins, synthetic organic and inorganic polymers. Compared with historical Journal Impact data, the Metric 2019 of Human gene therapy. Full articles available by subscription. According to the Journal Citation Report from 2011, the journals impact factor is rated at 3.710. The journal is published on a monthly basis by the Nature Publishing Group and is another of several journals from their collection that is devoted to Gene Therapy. Human Gene Therapy is the definitive peer-reviewed rapid-publication journal covering all aspects of human gene therapy. The Journal Impact Quartile of Human gene therapy. It also publishes Progress and Prospects reviews and News and Commentary articles, which highlight the cutting edge of the field. Cancer Gene Therapy - Publishes original laboratory and clinical research papers, case reports and review articles covering developments in gene transfer and gene therapy as applied to cancer research. Hillcoat Place, Edinburgh The Journal of Gene Medicine publishes high quality original articles and reviews on the science of gene transfer and its applications in gene and cell therapy. The journal is published on a monthly basis by the Nature Publishing Group and is one of several journals from their collection that is devoted to Gene Therapy. Trends in Molecular Medicine includes review articles on the genetic basis of disease, but 'molecular' does not only mean DNA. Access the archives for: Clinical development - Journal Impact. Impact Factor: *4.510 *2019 Journal Citation Reports (Clarivate, 2020) CiteScore™: 6.8 The first peer-reviewed journal in the field of human gene therapy, providing all-inclusive coverage of the research, methods, and clinical developments that are driving today's explosion of gene therapy advances. Journals: ISSN: 10430342, 15577422: Coverage: 1990-2020: Scope: Human Gene Therapy (HGT) is the premier, multidisciplinary journal covering all aspects of gene therapy. The Journal publishes scientific papers on original investigations into the transfer and expression of genes in mammals, including humans. The Journal of Genetic Syndromes & Gene Therapy is an academic journal – hosted by OMICS International – a pioneer in open access publishing–and is listed among the top 10 journals on Fungus. Clinical development is 2.400, which is just updated in 2020. Gene Therapy brings you the latest research into genetic and cell-based technologies to treat disease. The Journal publishes important advances in DNA, RNA, cell and immune therapies, validating the latest advances in research and new technologies. Each year research scientists have noticed a rise in the number of congresses being held in this field. Current Gene Therapy is an interdisciplinary journal focused on providing the readership with current and comprehensive reviews on all aspects of gene therapy. Twitter: @gentherev. The journal is adopted by the European and British Societies of Gene and Cell Therapy as their official journal. The journal is adopted by the European and British Societies of Gene and Cell Therapy as their official journal. United Kingdom, Email: [email protected] The journal is published by John Wiley and Sons. According to the Journal Citation Report from 2011, the journal's impact factor is rated at 4.218. The journal is aimed at all academic and industrial scientists who are interested in understanding either the pre-clinical or clinical research on gene therapy. Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechn, Researchers have taken a significant step forward in developing gen, Researchers found inserting genetic material into intestinal cells, Roberts Biosolutions Ltd Human Gene Therapy Impact Factor, IF, number of article, detailed information and … Impact Factor: * 4.510 *2019 Journal Citation Reports (Clarivate, 2020) The first peer-reviewed journal in the field of human gene therapy, providing all-inclusive coverage of the research, methods, and clinical developments that are driving today's explosion of gene therapy advances. The journal is aimed at all academic and industrial scientists who are interested in understanding either the pre-clinical or clinical research on gene therapy. The Journal Impact of an academic journal is a scientometric Metric that reflects the yearly average number of citations that … Clinical development dropped by 3.61% . The Journal Impact 2019-2020 of Human Gene Therapy is 3.670, which is just updated in 2020. Molecular Therapy Publishes original scientific papers in the areas of gene transfer, gene regulation, gene discovery, cell therapy, experimental models, correction of genetic and acquired diseases, and clinical trials. is an interdisciplinary journal focused on providing the readership with current and comprehensive reviews on all aspects of gene therapy. The Journal Impact Quartile of Human Gene Therapy is Q1 . Compared with historical Journal Impact data, the Metric 2019 of Human Gene Therapy dropped by 15.63% . Key areas of interest are the design and production of vectors, delivery and targeting, gene expression and regulation, preclinical studies including animal models, developmental aspects and clinical trials.